New MBC med: Hi Everyone, New med... - SHARE Metastatic ...

SHARE Metastatic Breast Cancer
3,416 members3,898 posts

New MBC med

Snowcone16
Snowcone16

Hi Everyone,

New med approved by FDA. The only thing that is curious is that it has average of 27.5 months for those NOT previously treated with endocrine therapy. So, guess my question is - does Tamoxifen count? Does Ibrance/letrozole count? I’m sure they would still prescribe as option but wonder on the length of time for successful treatment then.

fda.gov/Drugs/InformationOn...

9 Replies
oldestnewest

Thank you for the article! I was a little confused when reading it as it appeared that it had already been approved! What the new news is, is that it us now approved for pre-peri menapausal women. There's probably some paper published that will give you some initial data on those who have had hormonal therapy already.

Snowcone16
Snowcone16
in reply to diamags

You’re right. I didn’t catch that it had been expanded. The other good news is that it only took a month to push it through FDA.

🤗

diamags
diamags
in reply to Snowcone16

That is good news!

What’s the name of drug? I’ll ask my NHI/NCI contact about it

blms
blms
in reply to blms

Oh just saw that it’s not for us

What is the name of the new one?

Kisqali is the name.

Thank you have not heard of that one.

Yes...works similar to Ibrance and when you google- you’ll see both. Has a 28 month average. And there are currently some trials going on to complement it w a couple other meds.

You may also like...